REPLIMUNE GROUP INC's ticker is REPL and the CUSIP is 76029N106. A total of 138 filers reported holding REPLIMUNE GROUP INC in Q1 2023. The put-call ratio across all filers is 0.41 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $272,382 | -47.7% | 32,311 | +6.1% | 0.05% | -53.2% |
Q3 2023 | $521,290 | -12.9% | 30,467 | +18.2% | 0.11% | -7.5% |
Q2 2023 | $598,333 | +44.6% | 25,768 | +10.0% | 0.12% | +0.8% |
Q1 2023 | $413,809 | -43.8% | 23,432 | -13.4% | 0.12% | -83.3% |
Q4 2022 | $736,059 | +54.3% | 27,061 | -2.1% | 0.71% | +63.0% |
Q3 2022 | $477,000 | -11.2% | 27,644 | -9.9% | 0.44% | +7.1% |
Q2 2022 | $537,000 | +4.9% | 30,695 | +1.7% | 0.41% | +69.7% |
Q1 2022 | $512,000 | -49.1% | 30,182 | -18.7% | 0.24% | -34.2% |
Q4 2021 | $1,006,000 | – | 37,105 | – | 0.37% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Omega Fund Management, LLC | 5,344,971 | $122,395,000 | 33.11% |
Corriente Advisors, LLC | 512,500 | $11,798,000 | 5.98% |
Bain Capital Life Sciences Investors, LLC | 2,122,415 | $48,858,000 | 4.55% |
BVF INC/IL | 1,691,834 | $38,946,000 | 2.12% |
Redmile Group, LLC | 3,330,999 | $76,680,000 | 1.41% |
EMERALD ADVISERS, LLC | 891,761 | $20,528,000 | 0.84% |
EMERALD MUTUAL FUND ADVISERS TRUST | 823,989 | $18,968,000 | 0.84% |
Penn Mutual Asset Management, LLC | 15,877 | $365,000 | 0.52% |
EAM Global Investors LLC | 54,274 | $1,249,000 | 0.46% |
Artal Group S.A. | 700,000 | $16,114,000 | 0.39% |